HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

lamivudine-adefovir combination

antiviral

Also Known As:

LMV-ADV combination

Networked: 4 relevant articles (2 outcomes, 0 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1.	Choe, Won Hyeok: 1 article (09/2014)
2.	Kim, Jeong Han: 1 article (09/2014)
3.	Ko, Soon Young: 1 article (09/2014)
4.	Kwon, So Young: 1 article (09/2014)
5.	Moon, Hee Won: 1 article (09/2014)
6.	Abe, Hiromi: 1 article (08/2010)
7.	Aikata, Hiroshi: 1 article (08/2010)
8.	Chayama, Kazuaki: 1 article (08/2010)
9.	Hatakeyama, Tsuyoshi: 1 article (08/2010)
10.	Hayes, C Nelson: 1 article (08/2010)

Related Diseases

1.	Chronic Hepatitis B 05/01/2009 - "A retrospective review was performed in eighteen patients with chronic hepatitis B who developed virologic breakthroughs during LMV-ADV sequential mono-therapy and treated with LMV-ADV combination therapy. " 08/01/2010 - "Importance of serum concentration of adefovir for Lamivudine-adefovir combination therapy in patients with lamivudine-resistant chronic hepatitis B." 09/01/2014 - "Hepatitis B surface antigen levels at 6 months after treatment can predict the efficacy of lamivudine-adefovir combination therapy in patients with lamivudine-resistant chronic hepatitis B." 05/01/2009 - "[Antiviral efficacy of lamivudine/adefovir combination therapy in chronic hepatitis b patients with resistance to lamivudine and adefovir consecutively]."
2.	Hepatitis B 08/01/2005 - "Mathematical analysis of viral kinetics during lamivudine-adefovir combination therapy has not yet been performed in patients with lamivudine-resistant hepatitis B. "

Related Drugs and Biologics

1.	Lamivudine (Epivir)
2.	adefovir
3.	Hepatitis B Surface Antigens (HBsAg)
4.	Antiviral Agents (Antivirals)

Related Therapies and Procedures

1.	Therapeutics
2.	Aftercare (After-Treatment)